NEW YORK (Reuters Health) – Pain associated with diabetic neuropathy is improved to a similar degree with daily amitriptyline or duloxetine, according to the results of a cross-over…
NEW YORK (Reuters Health) – As well as improving HbA1c, continuous glucose monitoring reduces the time spent in hypoglycemia for children and adults with type 1 diabetes on…
NEW YORK (Reuters Health) – Patients with type 2 diabetes have better glycemic control and less nausea when exenatide is given weekly rather than twice daily, according to…
NEW YORK (Reuters Health) -– A point-of-care test for beta-hydroxybutyrate in capillary blood is more specific than a urine dipstick for ketones in identifying diabetic ketoacidosis in emergency-department…
NEW YORK (Reuters Health) – A new clinical practice guideline from the American College of Physicians recommends strongly against the use of intensive insulin therapy to normalize high…
NEW YORK (Reuters Health) – Research shows that biliopancreatic diversion (BPD) significantly reduces renal and cardiovascular complications over 10 years in morbidly obese individuals with newly diagnosed type…
NEW YORK (Reuters Health) – In metformin-treated patients with type 2 diabetes, exenatide twice daily improves glycemic control to the same degree as insulin aspart twice daily, but…
NEW YORK (Reuters Health) – Insulin degludec, an ultra-long-acting basal insulin, provides glycemic control in type 1 diabetes similar to that of insulin glargine but with lower occurrence…
NEW YORK (Reuters Health) – Neither injectable nor oral contraceptives have a meaningful effect on glucose or insulin levels, researchers report in the January 2011 Obstetrics & Gynecology.…
NEW YORK (Reuters Health) – In comparison with results in adults with diabetes, hemoglobin A1c (HbA1C) testing in younger patients doesn’t have the same level of discrimination, researchers…